Stryker, Johnson & Johnson and Zimmer Biomet posted their first-quarter financial results for 2025 and data on their spine orthopedic sales.
Here is how they compare:
Total sales: $5.9 billion (+11.9%)
Orthopedics: $2.3 billion (+9.7%)
Hips: $443 million (+12.7%)
Knees: $639 million (+8.7%)
Spine: $166 million (-2.9%)
Net earnings: $654 million
Total sales: $1.9 billion (+1.1%)
Hips: $495 million (+0.9%)
Knees: $729.9 million (+0.6%)
Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $470.5 million (+3.9%)
Net earnings: $182 million
Medtech sales: $8 billion (+2.5%)
Orthopedic: $2.2 billion (-4.2%)
Spine, sports and other: $671 million (-10.8%)
Hips: $409 million (-3.1%)
Knees: $389 million (-3%)
Net earnings: $11 billion
